logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11207271 B1

PDFFull Text
Date of Patent:
Dec. 28, 2021

Filed:

Mar. 08, 2017

Mazindol ir/sr multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (adhd)

Applicant:

Nls-1 Pharma Ag, Stans, CH;

Inventors:

Alexander C. Zwyer, Teufen, CH;

Lewis P. Amsel, Sarasota, FL (US);

Virginia Schmith, Wrightsville Beach, NC (US);

Scott Brantley, Apex, NC (US);

Assignee:

NLS Pharmaceutics AG, Stans, CH;

Attorney:

Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.

Primary Examiner:

Robert A Wax

Assistant Examiner:

William Craigo

Int. Cl.
CPC ...
A61K 9/24 (2006.01); A61K 9/20 (2006.01); A61K 31/4188 (2006.01); A61K 33/26 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/209 (2013.01); A61K 9/2095 (2013.01); A61K 31/4188 (2013.01); A61K 33/26 (2013.01); A61K 9/0053 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to a modified-release composition of mazindol and its use in the treatment of attention deficit disorders (ADD) or attention deficit/hyperactivity disorder (ADHD) or related deficit of alertness (i.e., incoercible sleepiness) or decline of vigilance (i.e., daytime somnolence) or excessive daytime sleepiness (e.g., narcolepsy, idiopathic hypersomnia) in particular in children, adolescents and adults.

Find Patent Forward Citations

Zwyer, Alexander. (2021). Mazindol ir/sr multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (adhd) (U.S. Patent No. 11207271). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11207271

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…